The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shishkova V.N.

Tsentr patologii rechi i neĭroreabilitatsii, Moskva

Happy at any age

Authors:

Shishkova V.N.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2024;(6‑7): 26‑32

Read: 352 times

To cite this article:

Shishkova VN. Happy at any age. Non Nocere. New Therapeutic Journal. 2024;(6‑7):26‑32. (In Russ.)

References:

  1. Rees M, Bitzer J, Cano A, Ceausu I, Chedraui P, Durmusoglu F, et al. Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement. Maturitas. 2021;151:55-62.  https://doi.org/10.1016/j.maturitas.2021.06.006
  2. Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol.Metab.Clin.North Am. 2015;44(3):497-515.  https://doi.org/10.1016/j.ecl.2015.05.001
  3. Zhu D, Chung HF, Dobson AJ, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020 Dec;223(6):898.e1-898.e16.  https://doi.org/10.1016/j.ajog.2020.06.039
  4. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the un-finished agenda of staging reproductive aging. Menopause. 2012 Apr;19(4):387-395.  https://doi.org/10.1097/gme.0b013e31824d8f40
  5. Ministry of Health of the Russian Federation. Clinical Recommendations “Menopause and menopausal state in a woman” [Electronic resource]. ID: 117. Year of approval: 2021. Date of circulation: 01.06.2024. https://cr.minzdrav.gov.ru/schema/117_2
  6. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-539.  https://doi.org/10.1001/jamainternmed.2014.8063
  7. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause – global prevalence, physiology and implications. Nat. Rev. Endocrinol. 2018;14(4):199-215.  https://doi.org/10.1038/nrendo.2017.180
  8. Costanian C, Zangiabadi S, Bahous SA, Deonandan R, Tamim H. Reviewing the evidence on vasomotor symptoms: the role of traditional and non-traditional factors. Climacteric. 2020 Jun;23(3):213-223.  https://doi.org/10.1080/13697137.2019.1711051
  9. Muka T, Oliver-Williams C, Colpani V, et al. Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. PLoS One. 2016 Jun 17;11(6): e0157417. https://doi.org/10.1371/journal.pone.0157417
  10. Shishkova V.N. Relationship between the development of cardiovascular diseases and metabolic disorders caused by magnesium deficiency. Cardiology. 2012;52(3):86-90. 
  11. Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause. 2014 Sep;21(9):924-932.  https://doi.org/10.1097/GME.0000000000000196
  12. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015 Apr;175(4):531-539.  https://doi.org/10.1001/jamainternmed.2014.8063
  13. Yureneva SV, Ermakova EI. The management of women with menopausal disorders (review of clinical guidelines). Russian Journal of Human Reproduction. 2017;23(5):115-122. (In Russ.) https://doi.org/10.17116/repro2017235115-122
  14. Shishkova V.N., Dranitsyna Yu.G., Drapkina O.M. Algorithms for the management of patients with anxiety in the internist’s practice. Cardiovascular Therapy and Prevention. 2023;22(2):3526. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3526
  15. Shishkova VN. Aging problems and hormone replacement therapy in postmenopausal women. Russian Bulletin of Obstetrician-Gynecologist. 2013;13(2):42-47. (In Russ.) https://www.mediasphera.ru/issues/rossijskij-vestnik-akushera-ginekologa/2013/2/031726-6122201329
  16. Fedin AI, Zaharov VV, Tanashyan MM, Chukanova EI, Madzhidova EN, Shchepankevich LA, Ostroumova OD. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO). S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):7-16. (In Russ.) https://doi.org/10.17116/jnevro20211211117
  17. Antipenko EA. Adaptogenic effects of mexidol in chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(3):44-49. (In Russ.) https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2012/3/031997-7298201238
  18. Lubarova I.B., Tikhonovskaya O.A., Alifirova V.M. Influence of cerebral blood circulation disorders on the course of the climacteric period in women. Bulletin of Siberian Medicine. 2008;2:84-89. 
  19. Kiseleva E.A., Makhmutkhodzhaev A.Sh., Mikheenko G.A. Effect of combined antioxidant and photodynamic therapy on the emotional state of patients with vulvar craurosis. Medical Herald of the South of Russia. 2023;14(1):5-12. (In Russ.) https://doi.org/10.21886/2219-8075-2023-14-1-5-12
  20. Chichanovskaya L.V., Solovieva A.V., Bakhareva O.N., Bryantseva M.V. Application of mexidol in patients with hypertensive encephalopathy of the postmenopausal period. Bulletin of experimental biology and medicine. 2012; Supplement 1:225-231. 
  21. Voronina TA, Ivanova EA. Combined administration of mexidol with known medicines. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4):115-124. (In Russ.) https://doi.org/10.17116/jnevro2019119041115

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.